Showing 1 – 2 of 2
Relevance | Newest | Oldest |
  • Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma

    Abstract Full Text
    free access
    JAMA Oncol. 2019; 5(10):1440-1447. doi: 10.1001/jamaoncol.2019.1558

    This biomarker analyss of patients with adrenocortical carcinoma compares the molecular classification for prognostic assessment of adrenocortical carcinoma with other known prognostic factors.

  • Association of PDGFRB Mutations With Pediatric Myofibroma and Myofibromatosis

    Abstract Full Text
    JAMA Dermatol. 2019; 155(8):946-950. doi: 10.1001/jamadermatol.2019.0114

    This study assesses the frequency of PDGFRB mutations in sporadic solitary myofibroma and multifocal myofibromatosis found in samples from an international population of adults and children and describes their use as a diagnostic biomarker and a therapeutic target.